News Releases

Date Title and Summary Additional Formats
March 3, 2020 Ayala Pharmaceuticals Granted U.S. FDA Fast Track Designation For AL101 For The Treatment Of Recurrent Or Metastatic Adenoid Cystic Carcinoma
REHOVOT, Israel & WILMINGTON, Del., March 2, 2020 – (BUSINESS WIRE) – Ayala Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today announced that the U.S.
Displaying 11 - 11 of 11